RecruitingNCT07205510
Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)
Sponsor
RenJi Hospital
Enrollment
10,000 participants
Start Date
Dec 1, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to establish an ambispective cohort platform centered on the pathological axis of "sarcopenia-metabolic disorders-aging progression", integrating multimodal data including demographic characteristics, lifestyle factors, clinical phenotypes, laboratory tests, medical imaging, and biospecimens. Namely 'Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)'.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Adults aged 18 and over
Exclusion Criteria5
- Does not cooperate in signing the informed consent form;
- Does not possess legal capacity;
- In a state of loss of consciousness;
- Suffering from severe mental illness, unable to communicate normally;
- The researcher believes that the subject has a disease that affects the assessment of results and is unsuitable for inclusion.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERnothing
This is an observational study.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07205510
Related Trials
Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia
NCT073984951 location
Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery
NCT075003761 location
HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke
NCT074569561 location
Effect of Essential Aminoacid Supplementation and Exercise on Skeletal Muscle Function in Hemodialysis Patients
NCT058841381 location
The Influence of Movement Velocity Biofeedback on Muscle Activation and Self Perception in Older Adults With Sarcopenia
NCT068532751 location